| typ : |
Czasopismo |
|
| Zespoły badawcze : |
Indianapolis - Eli Lilly and Company, Lilly Research Laboratories |
| Autorzy : |
Bornstein M, Lo AY, Thomas PN, Wilham WL. |
| Tytuł : |
Moxalactam disodium compatibility with intramuscular and intravenous diluents. |
| Numer : |
Am J Hosp Pharm ; 39: 1495-1498. 1982 |
|
| Poziom wiarygodności : |
|
| stabilność fizyczną : |
|
| Stabilność chemiczna : |
|
| Inne metody : |
|
| Komentarze : |
|
Listy
 Lidocaine hydrochloride
|
 |
|
|
Moxalactam
|
 |
 |
 |
 |
20 & 333 mg/ml |
25°C |
 |
| 24 |
 |
|
|
|
|
|
20 & 333 mg/ml |
5°C |
 |
| 96 |
|
|
|
|
|
 |
2 mg/ml |
25°C |
|
| 24 |
|
|
|
|
|
|
2 mg/ml |
5°C |
|
| 96 |
|
|
|
|
|
 |
20 mg/ml |
25°C |
|
| 24 |
|
|
|
|
|
|
20 mg/ml |
5°C |
|
| 96 |
|
|
|
|
|
 |
20 mg/ml |
25°C |
|
| 24 |
|
|
|
|
|
|
20 mg/ml |
5°C |
|
| 96 |
|
|
|
|
|
 |
20 mg/ml |
25°C |
|
| 24 |
|
|
|
|
|
|
20 mg/ml |
5°C |
|
| 96 |
|
|
|
|
|
 |
333 mg/ml |
25°C |
|
| 24 |
|
|
|
|
|
|
333 mg/ml |
5°C |
|
| 24 |
|
|
|
|
|
 |
333 mg/ml |
25°C |
|
| 24 |
|
|
|
|
|
|
333 mg/ml |
5°C |
|
| 96 |
|
|
|
|
|
 |
20 mg/ml |
25°C |
|
| 24 |
|
|
|
|
|
|
20 mg/ml |
5°C |
|
| 96 |
|
|
|
|
 |
|
20 mg/ml |
25°C |
|
| 24 |
|
|
|
|
|
|
20 mg/ml |
5°C |
|
| 96 |
|
|
|
|
|
| |
+
|
|
|
|
333 mg/ml |
+ Lidocaine hydrochloride
|
5 & 10 mg/ml |
+
|
 |
|
|
